Investigación en Enfermidades Hematolóxicas
University Hospital Bonn
Bonn, AlemaniaPublications in collaboration with researchers from University Hospital Bonn (2)
2023
-
Health-related quality of life following valoctocogene roxaparvovec gene therapy for severe hemophilia A in the phase 3 trial GENEr8-1
Journal of Thrombosis and Haemostasis
-
von Willebrand factor neutralizing and non-neutralizing alloantibodies in 213 subjects with type 3 von Willebrand disease enrolled in 3WINTERS-IPS
Journal of Thrombosis and Haemostasis, Vol. 21, Núm. 4, pp. 787-799